Meeting
2015 ASCO Annual Meeting
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases: The randomized phase III CAIRO5 study of the Dutch Colorectal Cancer Group.
Authors
Joost Huiskens
Academic Medical Centre, Amsterdam, Netherlands
Joost Huiskens , Thomas M van Gulik , Krijn P van Lienden , Marc R.W. Engelbrecht , Gerrit A. Meijer , Nicole C.T. van Grieken , Jonne Schriek , Astrid Keijser , Linda Mol , I. Quintus Molenaar , Cornelis Verhoef , Koert P. de Jong , Cornelis H.C. Dejong , Geert Kazemier , Theo Ruers , Johannes H.W. de Wilt , Harm van Tinteren , Cornelis J. A. Punt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT02162563
Citation
J Clin Oncol 33, 2015 (suppl; abstr TPS3622)
DOI
10.1200/jco.2015.33.15_suppl.tps3622
Abstract #
TPS3622
Poster Bd #
114a
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
FOLFOXIRI ± molecular targeting agent (bevacizumab or panitumumab) for conversion from unresectable to resectable in the advanced/recurrent colorectal cancer.
First Author: Kodai Takemori
First Author: Ramon Salazar
Poster
2020 ASCO Virtual Scientific Program
Real-world outcomes of patients with BRAF-mutated mCRC treated in the United States.
First Author: Matthew Braithwaite
Poster
2018 Gastrointestinal Cancers Symposium
PROX: Primary resistance to oxaliplatin containing regimen in the first line treatment of metastatic colorectal carcinoma—Retrospective analysis.
First Author: Larissa Machado